Portfolio company
DropPrint Genomics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops single-cell genomics software and an immune cell database for pharmaceutical researchers and biotechnology firms to improve drug discovery processes.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
QuirieGen
This company develops single-cell multi-omic technologies and AI models for drug discovery and development within the pharmaceutical sector.
Single Cell Discoveries
This company provides single-cell sequencing and spatial transcriptomics services to pharmaceutical, biotechnology and academic organisations to support drug discovery and biological research.
Enpicom
This company develops bioinformatics software for immune repertoire sequencing data analysis to assist biotechnology and pharmaceutical firms in antibody discovery and development.
Pepper Bio
This company develops transomics software to identify biological targets and drug candidates for pharmaceutical and biotechnology researchers.
Cellanome
This company develops a multi-omics platform that integrates imaging and sequencing for single-cell analysis to serve biotechnology researchers and drug developers.
Toxometris.ai
This company provides an artificial intelligence platform for predicting chemical toxicity and drug properties for pharmaceutical and biotechnology researchers.
54gene
This company provides genomic data and research services to pharmaceutical firms and researchers to improve global drug discovery and diagnostic development.
Stemnovate
This company develops human cell-based platforms for drug discovery and toxicity testing to support pharmaceutical firms and research institutions.
